Home → Tests → Phosphorus Test

Phosphorus Test

⚠️ Update approaching🔬 Evidence: ModerateInternal Medicine
Diğer adları: Phosphate, PO4, Serum phosphorus
⚠️

Discuss your test results with your doctor. This page is for informational purposes only and does not provide a diagnosis.

⚡ Key Facts

• Phosphorus is a key component of bone structure and essential for energy metabolism • Normal: 2.5–4.5 mg/dL (0.81–1.45 mmol/L) • Closely linked to kidney function and calcium balance • Levels vary with meals and time of day

🧪 What Does This Test Measure?

The phosphorus test measures inorganic phosphorus in the blood, a mineral essential for bone structure, energy metabolism, and cell function.

📋 Why Is It Ordered?

Ordered for kidney disease monitoring, bone metabolism evaluation, calcium disorder assessment, and nutritional status evaluation.

🔧 Preparation

Phosphorus levels vary with meals and time of day. Some laboratories recommend morning fasting collection.

📊 Reference Ranges

Normal: 2.5–4.5 mg/dL (0.81–1.45 mmol/L) Low (hypophosphatemia): <2.5 mg/dL High (hyperphosphatemia): >4.5 mg/dL ⚠️ Reference ranges vary by laboratory.

⬆️ High Values

High phosphorus (hyperphosphatemia) is most commonly associated with kidney disease. Excessive phosphorus intake and hypoparathyroidism may also contribute.

⬇️ Low Values

Low phosphorus (hypophosphatemia) may be associated with vitamin D deficiency, hyperparathyroidism, malnutrition, or refeeding syndrome.

⚙️ What Can Affect Results?

Kidney function, diet, medications, vitamin D status, and blood collection technique may affect phosphorus results.

🔬 Evidence Summary

Moderate evidence: 2 guidelines, 1 review, and 1 observational study.

📚 Most Important Studies on This Topic

1

KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)

Guideline· Kidney International Supplements · 2017 · PMID: 30675420

2

Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: whats changed and why it matters

Guideline· Kidney International · 2017 · PMID: 28646995

3

Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD

Review· Journal of the American Society of Nephrology · 2015 · PMID: 25967123

✅ Key Takeaways

💡

What you learned: Phosphorus is closely linked to kidney function and calcium metabolism. Abnormal levels require evaluation alongside calcium, vitamin D, and kidney function.

⛔

A phosphorus result alone cannot diagnose kidney or bone disease. Clinical context and additional tests are needed.

🔬 Sources Used on This Page

4 sources · Most recent publication: 2017
📋
Guideline
Expert society and guideline recommendations
2
sources
📖
Review
Comprehensive topic evaluation
1
source
👁
Observational
Observational and cohort studies
1
source
Overall assessment: Evidence level for this topic is moderate. This page is supported by 2 guidelines, 1 review, 1 observational study.

📝 Questions to Ask Your Doctor

Be prepared for your appointment. Add questions to your list.

📋 References

[PMID: 30675420] KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney International Supplements, 2017.
[PMID: 28646995] Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guideline Update: whats changed and why it matters. Kidney International, 2017.
[PMID: 25967123] Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. Journal of the American Society of Nephrology, 2015.
[PMID: 21389978] Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney International, 2011.
Last reviewed: 4/1/2026
Next review: 4/1/2027

🔗 Related Topics

🧪 Kalsiyum (Ca)🧪 Vitamin D🧪 Creatinine🧪 eGFR
⚖️ This page does not replace medical advice. Make treatment decisions with your doctor.
Content is based on scientific studies indexed in PubMed and current clinical guidelines.